FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367601301> ?p ?o ?g. }

• W4367601301 endingPage "634" @default.
• W4367601301 startingPage "634" @default.
• W4367601301 abstract "Although it has been postulated that chronic inflammation caused by rheumatoid arthritis (RA) contributes to the development of Parkinson disease (PD), the association between these 2 conditions has yet to be determined.To evaluate the association between RA and subsequent PD risk.This retrospective cohort study used the Korean National Health Insurance Service database to collect population-based, nationally representative data on patients with RA enrolled from 2010 to 2017 and followed up until 2019 (median follow-up, 4.3 [IQR, 2.6-6.4] years after a 1-year lag). A total of 119 788 patients who were first diagnosed with RA (83 064 with seropositive RA [SPRA], 36 724 with seronegative RA [SNRA]) were identified during the study period and included those who underwent a national health checkup within 2 years before the RA diagnosis date (64 457 patients). After applying exclusion criteria (eg, age <40 years, other rheumatic diseases, previous PD), 54 680 patients (39 010 with SPRA, 15 670 with SNRA) were included. A 1:5 age- and sex-matched control group of patients without RA was also included for a total control population of 273 400.Rheumatoid arthritis as defined using International Classification of Diseases, Tenth Revision codes M05 for SPRA and M06 (except M06.1 and M06.4) for SNRA; prescription of any disease-modifying antirheumatic drug; and enrollment in the Korean Rare and Intractable Diseases program.The main outcome was newly diagnosed PD. Data were analyzed from May 10 through August 1, 2022, using Cox proportional hazards regression analyses.From the 328 080 individuals analyzed (mean [SD] age, 58.6 [10.1] years; 74.9% female and 25.1% male), 1093 developed PD (803 controls and 290 with RA). Participants with RA had a 1.74-fold higher risk of PD vs controls (95% CI, 1.52-1.99). An increased risk of PD was found in patients with SPRA (adjusted hazard ratio [aHR], 1.95; 95% CI, 1.68-2.26) but not in patients with SNRA (aHR, 1.20; 95% CI, 0.91-1.57). Compared with the SNRA group, those with SPRA had a higher risk of PD (aHR, 1.61; 95% CI, 1.20-2.16). There was no significant interaction between covariates on risk of PD.In this study, RA was associated with an increased risk of PD, and seropositivity of RA conferred an augmented risk of PD. The findings suggest that physicians should be aware of the elevated risk of PD in patients with RA and promptly refer patients to a neurologist at onset of early motor symptoms of PD without synovitis." @default.
• W4367601301 created "2023-05-02" @default.
• W4367601301 creator A5001680111 @default.
• W4367601301 creator A5010345069 @default.
• W4367601301 creator A5021636463 @default.
• W4367601301 creator A5041508602 @default.
• W4367601301 creator A5047846074 @default.
• W4367601301 creator A5056517357 @default.
• W4367601301 creator A5065749375 @default.
• W4367601301 creator A5073374699 @default.
• W4367601301 creator A5083554387 @default.
• W4367601301 creator A5086029573 @default.
• W4367601301 date "2023-06-01" @default.
• W4367601301 modified "2023-10-02" @default.
• W4367601301 title "Rheumatoid Arthritis and Risk of Parkinson Disease in Korea" @default.
• W4367601301 cites W1980020952 @default.
• W4367601301 cites W1997211020 @default.
• W4367601301 cites W2008560062 @default.
• W4367601301 cites W2027096397 @default.
• W4367601301 cites W2040331803 @default.
• W4367601301 cites W2043291430 @default.
• W4367601301 cites W2046088592 @default.
• W4367601301 cites W2047402066 @default.
• W4367601301 cites W2053969387 @default.
• W4367601301 cites W2054597717 @default.
• W4367601301 cites W2058522899 @default.
• W4367601301 cites W2065896551 @default.
• W4367601301 cites W2073954164 @default.
• W4367601301 cites W2076743021 @default.
• W4367601301 cites W2100435187 @default.
• W4367601301 cites W2102841629 @default.
• W4367601301 cites W2110826367 @default.
• W4367601301 cites W2124712366 @default.
• W4367601301 cites W2127049275 @default.
• W4367601301 cites W2138192231 @default.
• W4367601301 cites W2166688610 @default.
• W4367601301 cites W2169448344 @default.
• W4367601301 cites W2341281672 @default.
• W4367601301 cites W2462712634 @default.
• W4367601301 cites W2528919078 @default.
• W4367601301 cites W2554445601 @default.
• W4367601301 cites W2622719965 @default.
• W4367601301 cites W2772742229 @default.
• W4367601301 cites W2802836877 @default.
• W4367601301 cites W2991140314 @default.
• W4367601301 cites W3019480645 @default.
• W4367601301 cites W3039563353 @default.
• W4367601301 cites W3047885384 @default.
• W4367601301 cites W3134757210 @default.
• W4367601301 cites W3213758127 @default.
• W4367601301 cites W36216970 @default.
• W4367601301 cites W4213209208 @default.
• W4367601301 cites W4230635088 @default.
• W4367601301 cites W4239844420 @default.
• W4367601301 cites W4242584870 @default.
• W4367601301 cites W4243028719 @default.
• W4367601301 cites W4243867794 @default.
• W4367601301 cites W4244076553 @default.
• W4367601301 cites W4251952032 @default.
• W4367601301 doi "https://doi.org/10.1001/jamaneurol.2023.0932" @default.
• W4367601301 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37126341" @default.
• W4367601301 hasPublicationYear "2023" @default.
• W4367601301 type Work @default.
• W4367601301 citedByCount "2" @default.
• W4367601301 countsByYear W43676013012023 @default.
• W4367601301 crossrefType "journal-article" @default.
• W4367601301 hasAuthorship W4367601301A5001680111 @default.
• W4367601301 hasAuthorship W4367601301A5010345069 @default.
• W4367601301 hasAuthorship W4367601301A5021636463 @default.
• W4367601301 hasAuthorship W4367601301A5041508602 @default.
• W4367601301 hasAuthorship W4367601301A5047846074 @default.
• W4367601301 hasAuthorship W4367601301A5056517357 @default.
• W4367601301 hasAuthorship W4367601301A5065749375 @default.
• W4367601301 hasAuthorship W4367601301A5073374699 @default.
• W4367601301 hasAuthorship W4367601301A5083554387 @default.
• W4367601301 hasAuthorship W4367601301A5086029573 @default.
• W4367601301 hasConcept C126322002 @default.
• W4367601301 hasConcept C167135981 @default.
• W4367601301 hasConcept C1862650 @default.
• W4367601301 hasConcept C2777575956 @default.
• W4367601301 hasConcept C2779134260 @default.
• W4367601301 hasConcept C2908647359 @default.
• W4367601301 hasConcept C50382708 @default.
• W4367601301 hasConcept C71924100 @default.
• W4367601301 hasConcept C72563966 @default.
• W4367601301 hasConcept C99454951 @default.
• W4367601301 hasConceptScore W4367601301C126322002 @default.
• W4367601301 hasConceptScore W4367601301C167135981 @default.
• W4367601301 hasConceptScore W4367601301C1862650 @default.
• W4367601301 hasConceptScore W4367601301C2777575956 @default.
• W4367601301 hasConceptScore W4367601301C2779134260 @default.
• W4367601301 hasConceptScore W4367601301C2908647359 @default.
• W4367601301 hasConceptScore W4367601301C50382708 @default.
• W4367601301 hasConceptScore W4367601301C71924100 @default.
• W4367601301 hasConceptScore W4367601301C72563966 @default.
• W4367601301 hasConceptScore W4367601301C99454951 @default.
• W4367601301 hasIssue "6" @default.
• W4367601301 hasLocation W43676013011 @default.

• next